Brief: Chuangmei Pharmaceutical sees FY net profit growth of 110%

Charmacy Pharmaceutical Co

24/01/2017 12:39

Jan 24 (Reuters) - Chuangmei Pharmaceutical Co Ltd  2289.HK  
    * Group is expected to record a growth of not less than 110 
pct in profit attributable for year ended 31 December 2016 
    * Expected result due to  increases in sales of products and 
gross profit of group 
 
Source text for Eikon:  ID:nHKS5x1Nyq  
Further company coverage:  2289.HK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))